Attached files

file filename
10-Q - FORM 10-Q - Anixa Biosciences Incd228343d10q.htm
EX-10.1 - EXCLUSIVE LICENSE AGREEMENT - Anixa Biosciences Incd228343dex101.htm
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER, PURSUANT TO SECTION 1350 - Anixa Biosciences Incd228343dex322.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER, PURSUANT TO SECTION 302 - Anixa Biosciences Incd228343dex312.htm
EX-10.2 - LICENSE AGREEMENT - Anixa Biosciences Incd228343dex102.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER, PURSUANT TO SECTION 302 - Anixa Biosciences Incd228343dex311.htm

Exhibit 32.1

Statement of Chief Executive Officer

Pursuant to Section 1350 of Title 18 of the United States Code

Pursuant to Section 1350 of Title 18 of the United States Code, the undersigned, Denis A. Krusos, the Chairman of the Board and Chief Executive Officer of CopyTele, Inc., hereby certifies that:

 

 

1.

The Company’s Form 10-Q Quarterly Report for the period ended July 31, 2011 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

   

/s/ Denis A. Krusos

   

Denis A. Krusos

   

Chairman of the Board and

September 14, 2011

   

    Chief Executive Officer